Show items per page
Elements: 302
Page 1 on 16
 TitleAuthors / EditorsDate
add to browser selection
Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermis Russo, Barbara; Borowczyk, Julia; Boehncke, Wolf-Henning; Truchetet, Marie-Elise; ... Chizzolini, Carlo 2021
add to browser selection
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement Nash, Peter; Kerschbaumer, Andreas; Dörner, Thomas; Dougados, Maxime; ... Smolen, Josef S 2021
add to browser selection
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure Armstrong, April; Paul, Carle; Puig, Luis; Boehncke, Wolf-Henning; ... Lebwohl, Mark G 2020
add to browser selection
Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation Del Río-Sancho, Sergio; Lapteva, Maria; Sonaje, Kiran; Böhler, Christof; ... Kalia, Yogeshvar 2020
add to browser selection
The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development Stalder Monney, Romaine; Zhang, Bin; Wrobel, Ludovic; Boehncke, Wolf-Henning; Brembilla, Nicolo 2020
add to browser selection
IL-17E (IL-25) and IL-17A differentially affect the functions of human keratinocytes Borowczyk, Julia; Buerger, Claudia; Tadjrischi, Neschaat; Drukala, Justyna; ... Brembilla, Nicolo 2020
add to browser selection
Traitement des kératoses actiniques : l’embarras du choix Muhlstadt, Michaël; Tzika, Evangelia; Boehncke, Wolf-Henning 2020
add to browser selection
Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study Boehncke, Wolf-Henning; Horváth, R; Dalkiliç, E; Lima, S A L; ... Lubrano, E 2020
add to browser selection
Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care da Silva, Neuza; Augustin, Matthias; Langenbruch, Anna; Mrowietz, Ulrich; ... Sommer, Rachel 2020
add to browser selection
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey Tillett, William; Merola, Joseph F; Thaçi, Diamant; Holdsworth, Elizabeth; ... Boehncke, Wolf-Henning 2020
add to browser selection
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase ii study Mease, Philip J; Gladman, Dafna D; Deodhar, Atul; McGonagle, Dennis G; ... Helliwell, Philip S 2020
add to browser selection
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; ... van der Heijde, Desirée 2020
add to browser selection
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial Deodhar, Atul; Helliwell, Philip S; Boehncke, Wolf-Henning; Kollmeier, Alexa P; ... Ritchlin, Christopher T 2020
add to browser selection
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Gossec, Laure; Baraliakos, Xenofon; Kerschbaumer, Andreas; de Wit, Maarten; ... Smolen, Josef S 2020
add to browser selection
Cytokines of the IL-17 family in psoriasis Lauffer, Felix; Eyerich, Kilian; Boehncke, Wolf-Henning; Asadullah, Khusru; ... Schön, Michael P 2020
add to browser selection
IL-17A in psoriasis and beyond: cardiovascular and metabolic implications von Stebut, Esther; Boehncke, Wolf-Henning; Ghoreschi, Kamran; Gori, Tommaso; ... Schäffler, Andreas 2020
add to browser selection
Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health-related quality of life from two randomized phase 3 studies Merola, J F; Papp, K A; Nash, P; Gratacós, J; ... Young, P 2020
add to browser selection
Les cytokines IL-17, une famille en expansion utilisée comme cible pour des thérapies anti-inflammatoires innovantes Boehncke, Wolf-Henning; Stalder Monney, Romaine; Brembilla, Nicolo Costantino 2020
add to browser selection
Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients Augustin, M; Sommer, R; Kirsten, N; Danckworth, A; ... Mrowietz, U 2019
add to browser selection
Un cas de « peau d'orange » sans cancer Boehncke, Wolf-Henning; Zürcher, Sven; Kaya, Gürkan 2019
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 ...15 | 16 |